➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Boehringer Ingelheim
McKinsey
Moodys
Johnson and Johnson

Last Updated: September 27, 2021

DrugPatentWatch Database Preview

Details for Patent: 6,861,409


Email this page to a colleague

« Back to Dashboard

Which drugs does patent 6,861,409 protect, and when does it expire?

Patent 6,861,409 protects MACRILEN and is included in one NDA.

This patent has sixty-two patent family members in twenty-nine countries.

Summary for Patent: 6,861,409
Title: Growth hormone secretagogues
Abstract:The invention relates to compounds of formula I ##STR1## which are useful for elevating the plasma level of growth hormone in a mammal as well for the treatment of growth hormone secretion deficiency, growth retardation in child and metabolic disorders associated with growth hormone secretion deficiency.
Inventor(s): Martinez; Jean (Saussan, FR), Fehrentz; Jean-Alain (St. Nazaire de Pezan, FR), Guerlavais; Vincent (Montpellier, FR)
Assignee: Zentaris AG (Frankfurt am Main, DE)
Application Number:09/880,498
Patent Claim Types:
see list of patent claims
Use; Composition; Compound;

Drugs Protected by US Patent 6,861,409

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Novo MACRILEN macimorelin acetate FOR SOLUTION;ORAL 205598-001 Dec 20, 2017 RX Yes Yes ⤷  Try it Free ⤷  Try it Free Y Y A METHOD FOR THE DIAGNOSIS OF ADULT GROWTH HORMONE DEFICIENCY BY MEASURING THE LEVEL OF GROWTH HORMONE AFTER ORAL ADMINISTRATION OF MACIMORELIN ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 6,861,409

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 029941 ⤷  Try it Free
Austria 302181 ⤷  Try it Free
Austria 362472 ⤷  Try it Free
Austria 370119 ⤷  Try it Free
Australia 2001266066 ⤷  Try it Free
Australia 6606601 ⤷  Try it Free
Bulgaria 107379 ⤷  Try it Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
Baxter
Johnson and Johnson
AstraZeneca
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.